NCT04788498

Brief Summary

The aim of this work is to evaluate the postoperative consequences of laparoendoscopic single site surgery relative to conventional laparoscopy in presumed benign ovarian cyst. The hypothesis is that single incision technique might offer advantages over the standard multi-port laparoscopy as potentially leading to less postoperative pain and improved cosmoses from a relatively hidden umbilical scar, as well as risk reduction of postoperative wound infection, hernia formation and elimination of multiple trocar site closure

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

March 5, 2021

Last Update Submit

March 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain

    The pain will be assessed by a numeric rating scale of 0-10

    at 24 hours ± 2 hour after the intervention

Secondary Outcomes (3)

  • Operative time

    intraoperative

  • the need for conversion to laparotomy

    intraoperative

  • the need to add an additional trocar

    intraoperative

Study Arms (2)

Laparoendoscpoic single site surgery LESS

EXPERIMENTAL

35 patients undergoing laparoscopic ovarian cystectomy A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp

Procedure: Laparoendoscpoic single site surgery LESS

Conventional multiport laparoscopy

ACTIVE COMPARATOR

35 patients undergoing laparoscopic ovarian cystectomy It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.

Procedure: Conventional multiport laparoscopy

Interventions

• A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp

Laparoendoscpoic single site surgery LESS

• It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.

Conventional multiport laparoscopy

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The patients are aged 18 to 45 years with BMI \< 35 kg/m2 and that they exhibit a surgical indication for a presumed benign ovarian pathology (PBOP) according to RCOG Guideline no. 62. 2011:
  • simple ovarian cysts \>7cm and \<15cm.
  • Persistent simple cyst for more than 3 months.
  • Symptomatic patients with complicated cyst (e.g. hemorrhagic cyst, torsion, etc)

You may not qualify if:

  • Previous midline laparotomies as suspected massive adhesions affecting intraoperative maneuvers and time.
  • Chronic pelvic pain, endometriosis or pelvic inflammatory diseases will be excluded to avoid pelvic adhesions and bias in the quantification of postoperative pain.
  • Do not possess a native umbilicus giving difficult access to single port.
  • The 'risk of malignancy index' (RMI) should be used to exclude those women at greater risk of malignancy. Using an RMI cut-off of 200, a sensitivity of 70% and specificity of 90% can be achieved. if features suggestive of malignancy are encountered, a gynecological oncologist should be consulted regarding further evaluation and staging.
  • Benign teratomas for the difficulty of extraction after removal that affects the intraoperative maneuvers and time.
  • Contraindication to any laparoscopy like any medical condition worsened by pneumoperitoneum or the Trendelenburg position.
  • Contraindication to general anesthesia as all laparoscopic procedures are done under GA.
  • Contraindication to non-steroidal anti-inflammatories, paracetamol, or tramadol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 5, 2021

First Posted

March 9, 2021

Study Start

May 1, 2021

Primary Completion

May 1, 2023

Study Completion

May 1, 2023

Last Updated

March 9, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share